Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Novel 99mTc-labeled Somatostatin Antaginosts in the Diagnostic Algotithm of Neuroendocrine Neoplasms - a Feasibility Study

NCT05871320 is registered in ClinicalTrials.gov with Jagiellonian University as lead sponsor.

NCT NCT05871320
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05871320 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Novel 99mTc-labeled Somatostatin Antaginosts in the Diagnostic Algotithm of Neuroendocrine Neoplasms - a Feasibility Study
Lead sponsor
Jagiellonian University
Phase
Phase 1
Overall status
Completed
Start date
December 23, 2022
Completion date
June 30, 2023
Enrollment
10 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

neuroendocrine tumors